Bioventus Inc Stock Ownership - Who owns Bioventus?

Insider buying vs selling

Have Bioventus Inc insiders been buying or selling?
William A. 1. HawkinsDirector2023-05-2544,000$2.66
William A. 1. HawkinsDirector2023-05-2444,000$2.69
Anthony P. Bihl IiiInterim CEO2023-05-23125,000$2.33
John A. BartholdsonDirector2023-05-22178,998$2.08
John A. BartholdsonDirector2023-05-191,136,675$1.94
Katrina J. ChurchSVP Chief Compliance Officer2023-04-03117$1.07
Mark Leonard SingletonSVP CFO2023-03-246,044$1.27
Kenneth Michael RealiChief Executive Officer2023-03-159,811$1.39
Katrina J. ChurchSVP Chief Compliance Officer2023-03-151,332$1.39
Anthony DadamioSVP General Counsel2023-03-153,409$1.39

1 of 2

BVS insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BVS insiders and whales buy or sell their stock.

BVS Shareholders

What type of owners hold Bioventus Inc stock?
Smith Nephew PLC21.12%16,534,814$46.63MInsider
Martin P. Sutter16.65%13,033,024$36.75MInsider
Ew Healthcare Partners Acquisition Fund LP16.64%13,021,324$36.72MInsider
Essex Woodlands Management Inc15.45%12,096,702$34.11MInstitution
John A. Bartholdson7.56%5,916,712$16.69MInsider
Nantahala Capital Management LLC6.61%5,173,469$14.59MInstitution
Juniper Investment Company LLC5.87%4,593,463$12.95MInstitution
Spindletop Healthcare Capital LP4.99%3,906,395$11.02MInsider
Ampcf Holdings LLC4.16%3,255,332$9.18MInsider
David J. Parker4.16%3,255,332$9.18MInsider

1 of 3

BVS vs Diagnostic & Research Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BVS33.33%66.67%Net BuyingNet Buying
CELC55.07%21.35%Net BuyingNet Buying
BNGO26.61%8.76%Net BuyingNet Selling
SRDX61.70%38.30%Net SellingNet Buying

Bioventus Stock Ownership FAQ

Who owns Bioventus?

Bioventus (NASDAQ: BVS) is owned by 39.94% institutional shareholders, 79.88% Bioventus insiders, and 0.00% retail investors. Smith Nephew PLC is the largest individual Bioventus shareholder, owning 16.53M shares representing 21.12% of the company. Smith Nephew PLC's Bioventus shares are currently valued at $49.94M.

If you're new to stock investing, here's how to buy Bioventus stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.